nelarabine
novartis
['leusm', 'nelarabine', 'elara']
david o connor from discusses induction failure (if) in children/aya w/ t-all from ukall2003/2011 -&gt; n=71, about 50% etp; 20% of t-all pts &gt;16 yrs w/ if! nelarabine -&gt; hct became more standard over time post-if but outcomes remain poor. #ash22 #leusm #allsm 1/x 
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????